Organisation / Company FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLICADA Department Administration Laboratory International Project Office Is the Hosting related to staff position within a Research Infrastructure? NoFounded in 1998, FIMA is the head entity of the Centro de Investigación Médica Aplicada (CIMA), a biomedical research institute of the University of Navarra. Inaugurated in 2004 with the mission of conducting translational research of excellence aimed at benefiting patients and society. We are the research center of the Clínica Universidad de Navarra. With our academic status, we work non-profit to achieve our scientific goal of addressing current clinical problems and proposing the most effective treatment for each patient. With more than 423 professionals, our research is multidisciplinary, carried out by teams of professionals from various fields (biologists, biochemists, pharmacists, engineers, doctors, laboratory technicians, etc.) We are leaders in research on cancer, heart diseases, and liver diseases, in the field of immunotherapy and gene therapy. The high specialization of our professionals in different biomedical areas is reflected in the research quality of their scientific publications, their international projects, and the development of therapeutic innovations. The research programmess are supported by 11 scientific platforms and an administrative team, with a strong focus on innovation and translation. In the past 10 years, CIMA has been awarded more than 700 projects at national and international level, and has an excellent track record in the EU framework with 49 funded actions. The Centre synergizes with the University Hospital (CUN) and collaborates with the pharmaceutical industry to develop products for diagnosis and treatment.We seek a motivated and independent researcher to develop a highly interdisciplinary project aimed at building a next generation human myocardium. Our research is focused at fabricating human cardiac tissue in the lab by using different additive manufacturing technologies (specially melt electrowriting) and human induced pluripotent stem cell (hiPSC)-derived cardiac cells. We seek to develop projects aimed at furthering our knowledge and capacity to better mimic the natural organisation of cardiac tissue. These objectives can include developing advanced biomaterials/biomaterial inks for bioprinting, designing improved scaffolds or composite tissues based on natural cardiac architecture or generating novel devices to advance the maturation and representativity of the engineered myocardium. Our equipment includes devices such as 3D printers (FDM, MEW), bioprinters (extrusion, volumetric), liquid culture cell bioreactor or electro-mechanical stimulation reactors. We have in-house animal models (rodents, pigs), and multi-transcriptomics (RNAseq in bulk, single cell and spatial, plus bioinformatic analysis). Our team collaborates with international experts that could act as secondments to boost the project´s impact.
#J-18808-Ljbffr